Viggiano, D.; Joshi, R.; Borriello, G.; Cacciola, G.; Gonnella, A.; Gigliotti, A.; Nigro, M.; Gigliotti, G.
SGLT2 Inhibitors: The First Endothelial-Protector for Diabetic Nephropathy. J. Clin. Med. 2025, 14, 1241.
https://doi.org/10.3390/jcm14041241
AMA Style
Viggiano D, Joshi R, Borriello G, Cacciola G, Gonnella A, Gigliotti A, Nigro M, Gigliotti G.
SGLT2 Inhibitors: The First Endothelial-Protector for Diabetic Nephropathy. Journal of Clinical Medicine. 2025; 14(4):1241.
https://doi.org/10.3390/jcm14041241
Chicago/Turabian Style
Viggiano, Davide, Rashmi Joshi, Gianmarco Borriello, Giovanna Cacciola, Annalisa Gonnella, Andrea Gigliotti, Michelangelo Nigro, and Giuseppe Gigliotti.
2025. "SGLT2 Inhibitors: The First Endothelial-Protector for Diabetic Nephropathy" Journal of Clinical Medicine 14, no. 4: 1241.
https://doi.org/10.3390/jcm14041241
APA Style
Viggiano, D., Joshi, R., Borriello, G., Cacciola, G., Gonnella, A., Gigliotti, A., Nigro, M., & Gigliotti, G.
(2025). SGLT2 Inhibitors: The First Endothelial-Protector for Diabetic Nephropathy. Journal of Clinical Medicine, 14(4), 1241.
https://doi.org/10.3390/jcm14041241
